Ali Poyan Mehr
Nephrology · Boston, MANPI 1912164583
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Novartis at 57.5% of the total. Reporting peaked in 2024 at $5,207 and has fallen 95.8% since, to $218 in 2025.
Across 19 payments — averaging $302.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3K
- Travere Therapeutics, Inc.$2K
- Calliditas Therapeutics US Inc.$344
- Aurinia Pharma U.S., Inc.$112
- Vertex$73
- Amgen$55
Across 89 payments — averaging $5493.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$369K
- Genentech, Inc.$120K
What the payments were for
- Consulting fees$3,30057%
- Travel & lodging$1,02218%
- Food & beverage$1,42025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 1 | $3,300 |
| Travere Therapeutics, Inc. | 9 | $1,858 |
| Calliditas Therapeutics US Inc. | 5 | $344 |
| Aurinia Pharma U.S., Inc. | 2 | $112 |
| Vertex | 1 | $73 |
| Amgen | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TARPEYO$244
How this compares
$5,742 in reported general payments places this provider in the 80th percentile of 339 nephrology providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 14 | $167 |
| Atorvastatin Calcium | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Boston
- David FriedmanBoston$19.8M
- Martin PollakBoston$19.8M
- Dennis AusielloBoston$4.6M
- Ajay SinghBoston$916K
- Leslie FangBoston$388K
- Jean FrancisBoston$244K
- Joseph BonventreBoston$175K
- Andrew AllegrettiBoston$139K
- Ravi ThadhaniBoston$115K
- Meghan SiseBoston$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.